Clinical trials
Active, not recruiting Phase 2 Gallbladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Asan Medical Center | 1 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 9 |
| Cholangiocarcinoma | 7 |
| Biliary Tract Neoplasms | 3 |
| Carcinoma, Adenoid Cystic | 2 |
| Carcinosarcoma | 2 |
| Hemangiosarcoma | 2 |
| Klatskin Tumor | 2 |
| Neurofibrosarcoma | 2 |
| Parathyroid Neoplasms | 2 |
| Thyroid Neoplasms | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.